Mirati Therapeutics | Spese Operative



Operating Expenses Cambiamento Data
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amgen USD 6.86B 85M 2025-03
Astellas Pharma JPY 395.77B 237.82B 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Bayer EUR 11.41B 3.22B 2025-03
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Eisai JPY 189.26B 684M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Exelixis USD 368.59M 34.96M 2025-04
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
J&J USD 8.26B 10.37B 2025-03
Merck USD 9.66B 1.67B 2025-03
Moderna USD 1.16B 1.06B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Takeda JPY 1.13T 51.15B 2025-03
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03



Mirati Therapeutics Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.